May 03 2024

Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up

Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while competition from rival Eli Lilly...Reuters Health Information (Source: Medscape Diabetes Headlines)

MedWorm Message:

Read More

MedWorm • Diabetes for Patients • 0